• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Teva Pharmaceutical Industries Ltd., Tel Aviv, Israel, Tel Aviv, Israel

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 1 of 1

  • Page:
  • 1

Efficacy and Safety of Fremanezumab for the Preventive Treatment of Episodic Migraine in Children and Adolescents: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study

Author:Hershey, Andrew D.   Szperka, Christina L.   Barbanti, Piero   Pozo-Rosich, Patricia   Bittigau, Petra   Barash, Steve   Garnett, Sally   Bryson, Juline   Kessler, Yoel   Carmeli Schwartz, Yael   Ning, Xiaoping   

Session Name:PL5: Clinical Trials Plenary Session  

Topic:Headache  

Program Number:PL5.001  

Author Institution:Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA, Cincinnati, OH  Children’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA  Headache and Pain Unit, IRCCS San Raffaele, Rome, Italy, and San Raffaele University, Rome, Italy, Rome, Italy  Headache Unit and Research Group, Vall d’Hebron Hospital and Research Institute, Universitat Autonoma de Barcelona, Barcelona, Spain, Barcelona, Spain  Charité-Universitätsmedizin Berlin, Berlin, Germany, Berlin, Germany  Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA, West Chester, PA  Teva Pharmaceutical Industries Ltd., Tel Aviv, Israel, Tel Aviv, Israel  

  • View Abstract
  • View Disclosure

Displaying 1 - 1 of 1

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com